Short sellers trimmed positions by 5.5% over the past week as TRU heads into Tuesday's print. Options sentiment remains bearish, while analysts cluster around neutral ratings with a $92 price target implying 27% upside.
Short interest stands at 8.92 million shares as of April 23, representing 4.59% of free float. Shorts have reduced positions by 5.5% over the past week and 1.9% in the last trading day. Days to cover sits at 5.08 based on official FINRA data. Cost to borrow remains benign at 0.51%, down 6.4% week-over-week. Utilisation has fallen to 15.01%, well below the 52-week peak of 21.6%. The retreat suggests short sellers are de-risking ahead of the quarterly release.
Put-call ratio registered 0.23 on April 24, running one standard deviation below the 20-day mean of 0.42. The PCR sits near the lower end of its 52-week range (0.05 to 0.98). The skew toward call activity suggests tactical bullishness, but the sustained low PCR levels over the past week point to reduced hedging demand rather than conviction positioning.
Mizuho initiated coverage with a Neutral rating and $80 target on April 16. UBS lowered its target to $69 from $72 on April 13, maintaining Neutral. Earlier, Morgan Stanley cut its Overweight target to $100 from $105 on March 11, while Goldman Sachs trimmed its Neutral price target to $80 from $92 in mid-February. The consensus target of $92 sits 27% above the current $72.61 close. Recent downgrades followed mixed FY26 guidance. Benzinga's bull case highlights 13% Q4 revenue growth and 19% year-over-year gains in financial services, driven by mortgage and consumer lending. The bear case warns that overly optimistic mortgage volume assumptions and Indian market headwinds cloud the outlook, with Q4 adjusted EBITDA guidance falling short of consensus.
P/E multiple stands at 14.5, up 1.1 points over the past month. EV/EBITDA contracted to 9.95, down 0.14 over 30 days. Price-to-book sits at 2.97, up 0.19 month-over-month. TransUnion ranks in the 35th percentile on 12-month forward EPS growth and the 32nd percentile on earnings surprise. EPS momentum shows improvement, ranking in the 55th percentile over 90 days versus the 16th percentile over 30 days.
Insiders sold $11.0 million net over the past 90 days, including a $3.4 million sale by CEO Christopher Cartwright on February 27. Vanguard added 46,945 shares in Q1, lifting its stake to 9.65%. BlackRock increased holdings by 21,445 shares to 9.45%. T. Rowe Price trimmed its position by 599,664 shares in Q4, reducing ownership to 4.05%.
The stock dropped 7.2% over the past week, giving back gains from the prior month. Previous earnings prints on February 18 and March 10 triggered volatile intraday moves, with the stock closing mixed on both occasions.
No active ORTEX Alpha signals are currently firing for TransUnion.
See the live data behind this article on ORTEX.
Open TRU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
